I am currently in my senior year at the University of Southern California, where I am double majoring in business administration and accounting. After completing my degree, I plan to sit for the CPA and work several years in public accounting before assessing my options again. I am very interested in emerging, clinical-stage biotech companies, and specialize in researching and uncovering companies which are undervalued heading into catalyst events. In biotech, every investor will have losers, and sometimes big losers; picking big winners and small losers is key for success in trading this industry. As such, my overall strategy hinges on finding and investing in companies with minimal downside but strong potential upside.